anastrozole sold brand name arimidex among others antiestrogenic medication used addition treatments breast specifically used hormone receptorpositive breast also used prevent breast cancer high taken common side effects anastrozole include hot flashes altered mood joint pain severe side effects include increased risk heart disease use pregnancy may harm anastrozole aromataseinhibiting family works blocking production estrogens body hence antiestrogenic anastrozole patented approved medical use world health organizations list essential anastrozole available generic commonly prescribed medication united states million anastrozole used treatment prevention breast cancer arimidex tamoxifen alone combination atac trial localized breast cancer women received either anastrozole selective estrogen receptor modulator tamoxifen five years followed five years years group received anastrozole better results tamoxifen trial suggested anastrozole preferred medical therapy postmenopausal women localized estrogen receptorpositive breast anastrozole used dosage mgday combination antiandrogen bicalutamide treatment peripheral precocious puberty instance due familial malelimited precocious puberty testotoxicosis syndrome anastrozole available form mg oral alternative forms routes contraindications anastrozole include hypersensitivity anastrozole component anastrozole formulations pregnancy hypersensitivity reactions anastrozole including anaphylaxis angioedema urticaria common side effects anastrozole incidence include hot flashes asthenia arthritis pain arthralgia hypertension depression nausea vomiting rash osteoporosis bone fractures back pain insomnia headache bone pain peripheral edema coughing dyspnea pharyngitis serious rare adverse effects incidence include skin reactions lesions ulcers blisters allergic reactions swelling face lips tongue andor throat may cause difficulty swallowing breathing abnormal liver function tests well anastrozole thought clinically negligible inhibitory effects cytochrome enzymes result thought drug interactions anastrozole cytochrome substrates clinically significant drug interactions reported anastrozole anastrozole affect circulating levels tamoxifen major metabolite however tamoxifen found decrease steadystate areaunderthecurve levels anastrozole estradiol levels significantly different group received anastrozole tamoxifen compared anastrozole alone group decrease anastrozole levels thought clinically anastrozole works reversibly binding aromatase enzyme competitive inhibition blocks conversion androgens estrogens peripheral extragonadal medication found achieve inhibition aromatase dosage mgday inhibition aromatase dosage mgday mgday considered minimal dosage required achieve maximal suppression aromatase decrease aromatase activity results least decrease estradiol levels postmenopausal levels corticosteroids adrenal steroids unaffected bioavailability anastrozole humans unknown found wellabsorbed absorption anastrozole linear dosage range mgday humans change repeated food significantly influence extent absorption peak levels anastrozole occur median hours administration wide range steadystate levels anastrozole achieved within days continuous administration however maximal suppression estradiol levels occurs within days active efflux anastrozole pglycoprotein barrier found limit central nervous system penetration anastrozole rodents whereas case letrozole anastrozole may peripheral selectivity humans although yet case estradiol synthesized peripherally readily crosses barrier anastrozole would still expected reduce estradiol levels central nervous system certain degree plasma protein binding anastrozole metabolism anastrozole ndealkylation hydroxylation inhibition aromatase due anastrozole rather metabolites major circulating metabolite elimination halflife anastrozole hours allows convenient oncedaily medication eliminated predominantly metabolism liver also residual excretion kidneys unchanged anastrozole excreted primarily urine also lesser extent anastrozole nonsteroidal also known anastrozole structurally related letrozole fadrozole vorozole classified anastrozole patented imperial chemical industries ici approved medical use specifically treatment breast cancer anastrozole generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved name jantooltip japanese accepted anastrozole primarily sold brand name however also marketed variety brand names throughout anastrozole available widely throughout anastrozole surprisingly ineffective treating gynecomastia contrast selective estrogen receptor modulators like anastrozole development treatment female infertility complete development hence never approved anastrozole levonorgestrel vaginal ring developmental code name bay development use hormonal contraceptive treatment endometriosis development discontinued november formulation never anastrozole increases testosterone levels males studied alternative method androgen replacement therapy men however concerns longterm influence bone mineral density patient population well adverse httpsenwikipediaorgwikianastrozole